Global Esoteric Testing Market Size, Share, and Growth & Trends Analysis By Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other) By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Real Time Polymerase Chain Reaction, DNA Sequencing, Flow Cytometry, Other Technologies) By End User (Hospital-based Laboratories, Independent and Reference Laboratories) By Region (North America, Asia Pacific, Europe, Middle East & Africa, South America): Regional Outlook, Growth Potential and Segments Forecast 2024-20

Loading...

Summary of Report:

The Global Esoteric Testing Market size was USD 24.2 billion in 2023 and is projected to reach USD 68.5 billion by 2031, with a CAGR of 11.5 % during the forecast period. 

Price

Original price was: $3,999.00.Current price is: $2,999.00.
Original price was: $4,999.00.Current price is: $3,999.00.
Original price was: $9,999.00.Current price is: $8,999.00.

Do You have any Budget constraints?
Simply Ask our Sales Team About it.

Loading...

Description

The Global Esoteric Testing Market size was USD 24.2 billion in 2023 and is projected to reach USD 68.5 billion by 2031, with a CAGR of 11.5 % during the forecast period. 

Global Esoteric Testing Market: Overview

The Esoteric Testing Market is experiencing substantial growth due to developing technology. Biomarker evaluation, digital PCR, next-generation sequencing, pyrosequencing, Sanger sequencing, and digital microfluidic systems are all changing diagnosis.

These advances enable the precise identification of genetic mutations and disease-associated molecular markers, therefore paving the door for personalised therapy and better patient outcomes. Advanced molecular phenotyping methods improve diagnostic accuracy by performing thorough molecular analyses.

Quest Diagnostics had just been released its first consumer-initiated genetic test, that employs cutting-edge technology to evaluate hereditary illnesses. LabCorp developed a new Neurofilament Light Chain (NFL) blood test for the swift identification of neurodegenerative illness indicators. Scarlet Health, developed by OPKO Health, is a complete in-home diagnostic platform that increases access to healthcare.

Government actions are also driving the market ahead. The United States government promotes high-quality healthcare by increasing reimbursement for diagnostic testing, but the European Union’s Horizon 2020 programme encourages personalised medicine and novel diagnostics. Asian governments are investing in facilities for healthcare along with research, fuelling demand for specialised testing services in the region.

Global Esoteric Testing Market: Covid-19 Impact

The COVID-19 pandemic has significantly impacted the esoteric testing market, leading to a surge in demand for specialized diagnostic tests. Laboratories have witnessed increased testing volumes for rare diseases, genetic disorders, and immune function assessments alongside COVID-19 testing. This trend has prompted innovation and expansion within the esoteric testing sector, with labs adapting to meet evolving healthcare needs amidst the ongoing public health crisis.

Global Esoteric Testing Market: Growth Drivers

  • Advancements in Technology:

Technological innovations such as next-generation sequencing (NGS), high-performance liquid chromatography (HPLC), and mass spectrometry have greatly enhanced the capabilities and accuracy of esoteric testing. These advancements attract both healthcare providers and patients seeking more precise diagnoses and personalized treatment options.

  • Rising Incidence of Complex Diseases: 

The increasing prevalence of complex diseases, such as cancer, autoimmune disorders, and genetic conditions, is driving the demand for esoteric testing. These tests offer insights into disease progression, treatment efficacy, and prognosis, thereby facilitating better clinical management and patient outcomes.

  • Growing Emphasis on Precision Medicine: 

Precision medicine, which tailors’ medical treatment to the individual characteristics of each patient, relies heavily on advanced diagnostic tools like esoteric testing. As healthcare systems worldwide shift towards personalized care models, the demand for esoteric tests that provide detailed genetic, molecular, and biochemical information is expected to surge.

Global Esoteric Testing Market: Restraining Factors

  • High Cost:

Esoteric tests are often expensive due to their complexity, specialized equipment requirements, and the need for highly trained personnel. The high cost can be a barrier to widespread adoption, particularly in resource-constrained healthcare settings or regions with limited insurance coverage for such tests.

  • Regulatory Challenges:

Esoteric tests are subject to stringent regulatory oversight to ensure their accuracy, reliability, and safety. Navigating the complex regulatory landscape, obtaining approvals, and complying with evolving regulations can pose challenges for laboratories and diagnostic companies, potentially delaying market entry or product launches.

Global Esoteric Testing Market:  Opportunity Factors

  • Expansion of Testing Menu:

Diagnostic companies and laboratories can capitalize on the growing demand for esoteric testing by expanding their test menu to cover a wider range of diseases, conditions, and biomarkers. Developing novel assays, panels, or platforms that address unmet clinical needs or emerging healthcare trends can create lucrative opportunities for growth and differentiation.

  • Partnerships and Collaborations:

Collaborating with healthcare providers, research institutions, pharmaceutical companies, and technology partners can unlock new opportunities in the esoteric testing market. Strategic partnerships can facilitate access to specialized expertise, funding, patient cohorts, and complementary technologies, accelerating innovation and market penetration.

Global Esoteric Testing Market: Challenges

  • Data Interpretation Complexity:

Esoteric tests generate vast amounts of complex data, including genomic sequences, proteomic profiles, and metabolic signatures, which require sophisticated bioinformatics and data analytics capabilities for accurate interpretation. Addressing the challenges associated with data standardization, integration, storage, analysis, and interpretation remains a significant hurdle for many healthcare organizations and laboratories.

  • Reimbursement Issues:

Reimbursement policies vary widely for esoteric tests, and obtaining adequate reimbursement from payers can be challenging. Demonstrating the clinical utility, cost-effectiveness, and long-term value of esoteric testing to insurers and reimbursement authorities is essential but often requires robust clinical evidence and health economic evaluations. Lack of reimbursement or inadequate reimbursement rates can hinder market adoption and profitability, particularly for smaller diagnostic companies or niche tests.

Global Esoteric Testing Market: Segmentation

Based on Type: The market is segmented into Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other.

Based on Technology: The market is segmented into Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Real Time Polymerase Chain Reaction, DNA Sequencing, Flow Cytometry, Other Technologies.

Based on End User: The market is segmented into Hospital-based Laboratories, Independent and Reference Laboratories.

Global Esoteric Testing Market: Regional Insights

  • North America:

The Esoteric Testing Market in North America is expected to increase significantly, led by factors such as the rising frequency of chronic and infectious diseases and the growing demand for specialised diagnostic tests. Leading companies including the Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., and Stanford Health Care are driving innovation and growth in this industry.

Technological breakthroughs like as next-generation DNA sequencing and instantaneous polymerase chain reaction are driving market expansion. Despite constraints such as the expensive nature of esoteric testing processes, possibilities abound as these techniques become more widely adopted and demand for specialised diagnostics grows. North America is likely to lead the market share in 2024, but the Asia Pacific area shows potential, with the fastest projected increase in growth through 2029.

  • Asia Pacific:

The Asia Pacific esoteric testing market is growing rapidly due to reasons such as an increasing number of long-term diseases, increased demand for prompt and accurate diagnosis, and developments in healthcare infrastructure. Esoteric testing is the specialised laboratory examination of rare and complex health issues, which provides insights that conventional tests do not.

This region is experiencing an increase of demand for personalised medicine, which has raised the use of esoteric testing services. Furthermore, government programmes targeted at boosting access to healthcare and awareness are helping to drive market growth. To obtain a competitive advantage, key businesses are investing in strategic collaborations, technical advancements, and product portfolio expansion.

Competitive Landscape

  • ARUP Laboratories,
  • Stanford Health Care,
  • Mayo Foundation for Medical Education and Research,
  • Laboratory Corporation of America Holdings, Healius Limited,
  • F. Hoffmann-La Roche Ltd.,
  • Quest Diagnostics Inc.,
  • Athena Esoterix, LLC.,
  • Opko Health, Inc.,
  • Sonic Healthcare Limited

Global Esoteric Testing Market: Recent Developments

22 May 2024 – Roche announced that the Tina-quant lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) to identify patients who may benefit from innovative Lp(a)-lowering therapy currently in development. Lp(a) is emerging as an important, yet under-recognised, potential risk factor for cardiovascular disease, a major public health issue.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Advancements in Technology
3.3. Restraints
3.3.1. High Cost
3.4. Opportunities
3.4.1. Expansion of Testing Menu
3.5. Challenges
3.5.1. Data Interpretation Complexity
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. By TYPE
4.7.2. By TECHNOLOGY
4.7.3. By END USER
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL ESOTERIC TESTING MARKET, BY TYPE
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global Esoteric Testing MARKET Share, by TYPE -2023 and 2031 (%)
6.2. INFECTIOUS DISEASE TESTING
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. ONCOLOGY TESTING
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
6.4. ENDOCRINOLOGY TESTING
6.4.1. Key market Trends, Growth Factors, and Opportunities
6.4.2. Market Size and Forecast, by Regions
6.5. GENETIC TESTING
6.5.1. Key market Trends, Growth Factors, and Opportunities
6.5.2. Market Size and Forecast, by Regions
6.6. TOXICOLOGY TESTING
6.6.1. Key market Trends, Growth Factors, and Opportunities
6.6.2. Market Size and Forecast, by Regions
6.7. IMMUNOLOGY TESTING
6.7.1. Key market Trends, Growth Factors, and Opportunities
6.7.2. Market Size and Forecast, by Regions
6.8. NEUROLOGY TESTING
6.8.1. Key market Trends, Growth Factors, and Opportunities
6.8.2. Market Size and Forecast, by Regions
6.8.3.
CHAPTER 7: GLOBAL ESOTERIC TESTING MARKET, BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. GLOBAL Esoteric Testing MARKET Share, TECHNOLOGY -2023 and 2031 (%)
7.2. ENZYME-LINKED IMMUNOSORBENT ASSAY
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. CHEMILUMINESCENCE IMMUNOASSAY
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
7.4. MASS SPECTROMETRY
7.4.1. Key market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Regions
7.5. REAL TIME POLYMERASE CHAIN REACTION
7.5.1. Key market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Regions
7.6. DNA SEQUENCING
7.6.1. Key market Trends, Growth Factors, and Opportunities
7.6.2. Market Size and Forecast, by Regions
7.7. FLOW CYTOMETRY
7.7.1. Key market Trends, Growth Factors, and Opportunities
7.7.2. Market Size and Forecast, by Regions
7.8. OTHERS
7.8.1. Key market Trends, Growth Factors, and Opportunities
7.8.2. Market Size and Forecast, by Regions

CHAPTER 8: GLOBAL ESOTERIC TESTING MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size & Forecast
8.1.2. Esoteric Testing Market Share, by END USER -2023 and 2031 (%)
8.2. HOSPITAL-BASED LABORATORIES
8.2.1. Key market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Regions
8.3. INDEPENDENT AND REFERENCE LABORATORIES
8.3.1. Key market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Regions
8.3.3.
CHAPTER 9: NORTH AMERICA MARKET ANALYSIS
9.1. Introduction
9.2. Esoteric Testing Market by Country
9.3. North America Esoteric Testing Market by Country, USD Million 2019-2031
9.3.1. Market Size & Forecast, By TYPE
9.3.2. Market Size & Forecast, by TECHNOLOGY
9.3.3. Market Size & Forecast, by END USER
9.4. U.S.
9.4.1. Market Size & Forecast, By TYPE
9.4.2. Market Size & Forecast, by TECHNOLOGY
9.4.3. Market Size & Forecast, by END USER
9.5. Canada
9.5.1. Market Size & Forecast, By TYPE
9.5.2. Market Size & Forecast, by TECHNOLOGY
9.5.3. Market Size & Forecast, by END USER
CHAPTER 10: EUROPE MARKET ANALYSIS
10.1. Introduction
10.2. Esoteric Testing Market by Country
10.3. Europe Esoteric Testing Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, By TYPE
10.3.2. Market Size & Forecast, by TECHNOLOGY
10.3.3. Market Size & Forecast, by END USER
10.4. Germany
10.4.1. Market Size & Forecast, By TYPE
10.4.2. Market Size & Forecast, by TECHNOLOGY
10.4.3. Market Size & Forecast, by END USER
10.5. France
10.5.1. Market Size & Forecast, By TYPE
10.5.2. Market Size & Forecast, by TECHNOLOGY
10.5.3. Market Size & Forecast, by END USER
10.6. U.K.
10.6.1. Market Size & Forecast, By TYPE
10.6.2. Market Size & Forecast, by TECHNOLOGY
10.6.3. Market Size & Forecast, by END USER
10.7. Italy
10.7.1. Market Size & Forecast, By TYPE
10.7.2. Market Size & Forecast, by TECHNOLOGY
10.7.3. Market Size & Forecast, by END USER
10.8. Spain
10.8.1. Market Size & Forecast, By TYPE
10.8.2. Market Size & Forecast, by TECHNOLOGY
10.8.3. Market Size & Forecast, by END USER
10.9. Benelux
10.9.1. Market Size & Forecast, By TYPE
10.9.2. Market Size & Forecast, by TECHNOLOGY
10.9.3. Market Size & Forecast, by END USER
10.10. Rest of Europe
10.10.1. Market Size & Forecast, By TYPE
10.10.2. Market Size & Forecast, by TECHNOLOGY
10.10.3. Market Size & Forecast, by END USER
CHAPTER 11: ASIA-PACIFIC MARKET ANALYSIS
11.1. Introduction
11.2. Esoteric Testing Market by Country
11.3. Asia Pacific Esoteric Testing Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, By TYPE
11.3.2. Market Size & Forecast, by TECHNOLOGY
11.3.3. Market Size & Forecast, by END USER
11.4. China
11.4.1. Market Size & Forecast, By TYPE
11.4.2. Market Size & Forecast, by TECHNOLOGY
11.4.3. Market Size & Forecast, by END USER
11.5. India
11.5.1. Market Size & Forecast, By TYPE
11.5.2. Market Size & Forecast, by TECHNOLOGY
11.5.3. Market Size & Forecast, by END USER
11.6. Japan
11.6.1. Market Size & Forecast, By TYPE
11.6.2. Market Size & Forecast, by TECHNOLOGY
11.6.3. Market Size & Forecast, by END USER
11.7. Australia
11.7.1. Market Size & Forecast, By TYPE
11.7.2. Market Size & Forecast, by TECHNOLOGY
11.7.3. Market Size & Forecast, by END USER
11.8. South Korea
11.8.1. Market Size & Forecast, By TYPE
11.8.2. Market Size & Forecast, by TECHNOLOGY
11.8.3. Market Size & Forecast, by END USER
11.9. Souethest Asia
11.9.1. Market Size & Forecast, By TYPE
11.9.2. Market Size & Forecast, by TECHNOLOGY
11.9.3. Market Size & Forecast, by END USER
11.10. Rest of Asia Pacific
11.10.1. Market Size & Forecast, By TYPE
11.10.2. Market Size & Forecast, by TECHNOLOGY
11.10.3. Market Size & Forecast, by END USER
CHAPTER 12: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
12.1. Introduction
12.2. Esoteric Testing Market by Country
12.3. Latin America Esoteric Testing Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, By TYPE
12.3.2. Market Size & Forecast, by TECHNOLOGY
12.3.3. Market Size & Forecast, by END USER
12.4. Brazil
12.4.1. Market Size & Forecast, By TYPE
12.4.2. Market Size & Forecast, by TECHNOLOGY
12.4.3. Market Size & Forecast, by END USER
12.5. Mexico
12.5.1. Market Size & Forecast, By TYPE
12.5.2. Market Size & Forecast, by TECHNOLOGY
12.5.3. Market Size & Forecast, by END USER
12.6. Rest of Latin America
12.6.1. Market Size & Forecast, By TYPE
12.6.2. Market Size & Forecast, by TECHNOLOGY
12.6.3. Market Size & Forecast, by END USER
CHAPTER 13: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
13.1. Introduction
13.2. Esoteric Testing Market by Country
13.3. MEA Esoteric Testing Market by Country, USD Million 2019-2031
13.3.1. Market Size & Forecast, By TYPE
13.3.2. Market Size & Forecast, by TECHNOLOGY
13.3.3. Market Size & Forecast, by END USER
13.4. South Africa
13.4.1. Market Size & Forecast, By TYPE
13.4.2. Market Size & Forecast, by TECHNOLOGY
13.4.3. Market Size & Forecast, by END USER
13.5. Saudi Arabia
13.5.1. Market Size & Forecast, By TYPE
13.5.2. Market Size & Forecast, by TECHNOLOGY
13.5.3. Market Size & Forecast, by END USER
13.6. UAE
13.6.1. Market Size & Forecast, By TYPE
13.6.2. Market Size & Forecast, by TECHNOLOGY
13.6.3. Market Size & Forecast, by END USER
13.7. Rest of MEA
13.7.1. Market Size & Forecast, By TYPE
13.7.2. Market Size & Forecast, by TECHNOLOGY
13.7.3. Market Size & Forecast, by END USER
CHAPTER 14: COMPETITIVE LANDSCAPE
14.1. Introduction
14.2. Market Player Positioning, 2022
14.3. Company Evaluation Matrix
14.4. Product Mapping of Top 10 Player
14.5. Market Opportunities and Future Trends
14.6. Competitive Heatmap
14.7. Top Winning Growth Strategies
14.7.1. Major Growth Strategies
14.7.2. Expansion
14.7.3. Merger and Acquisition
14.7.4. Other Developments
CHAPTER 15: COMPANY PROFILES
15.1. ARUP LABORATORIES
15.1.1. Company Overview
15.1.2. Key Executives
15.1.3. Financial Overview
15.1.4. Business TYPEnalysis
15.1.5. Product Portfolio
15.1.6. Key Strategic Developments
15.2. STANFORD HEALTH CARE
15.3. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
15.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
15.5. HEALIUS LIMITED
15.6. F. HOFFMANN-LA ROCHE LTD.
15.7. QUEST DIAGNOSTICS INC.
15.8. ATHENA ESOTERIX, LLC.
15.9. OPKO HEALTH, INC.
15.10. SONIC HEALTHCARE LIMITED
15.11. OTHERS

Tables and Figures

LIST OF TABLES
Table 1. GLOBAL Esoteric Testing MARKET INDUSTRY SNAPSHOT, 2022-2031
Table 2. GLOBAL Esoteric Testing MARKET SHARE, by TYPE -2019-2031 (USD MILLION)
Table 3. GLOBAL Esoteric Testing MARKET INFECTIOUS DISEASE TESTING, BY REGION-2019-2031 (USD MILLION)
Table 4. GLOBAL Esoteric Testing MARKET ONCOLOGY TESTING, BY REGION-2019-2031 (USD MILLION)
Table 5. GLOBAL Esoteric Testing MARKET ENDOCRINOLOGY TESTING, BY REGION-2019-2031 (USD MILLION)
Table 6. GLOBAL Esoteric Testing MARKET GENETIC TESTING, BY REGION-2019-2031 (USD MILLION)
Table 7. GLOBAL Esoteric Testing MARKET TOXICOLOGY TESTING, BY REGION-2019-2031 (USD MILLION)
Table 8. GLOBAL Esoteric Testing MARKET SHARE, by TECHNOLOGY SIZE-2019-2031 (USD MILLION)
Table 9. GLOBAL Esoteric Testing MARKET ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION-2019-2031 (USD MILLION)
Table 10. GLOBAL Esoteric Testing MARKET CHEMILUMINESCENCE IMMUNOASSAY, BY REGION-2019-2031 (USD MILLION)
Table 11. GLOBAL Esoteric Testing MARKET MASS SPECTROMETRY, BY REGION-2019-2031 (USD MILLION)
Table 12. GLOBAL Esoteric Testing MARKET REAL TIME POLYMERASE CHAIN REACTION, BY REGION-2019-2031 (USD MILLION)
Table 13. GLOBAL Esoteric Testing MARKET DNA SEQUENCING, BY REGION-2019-2031 (USD MILLION)
Table 14. GLOBAL Esoteric Testing MARKET SHARE, by END USER -2019-2031 (USD MILLION)
Table 15. GLOBAL Esoteric Testing MARKET HOSPITAL-BASED LABORATORIES, BY REGION-2019-2031 (USD MILLION)
Table 16. GLOBAL Esoteric Testing MARKET INDEPENDENT AND REFERENCE LABORATORIES, BY REGION-2019-2031 (USD MILLION)
Table 17. GLOBAL Esoteric Testing MARKET SHARE, REGION -2019-2031 (USD MILLION)
Table 18. GLOBAL Esoteric Testing MARKET FOR NORTH AMERICA, BY REGION-2019-2031 (USD MILLION)
Table 19. GLOBAL Esoteric Testing MARKET FOR ASIA PACIFIC BY REGION-2019-2031 (USD MILLION)
Table 20. GLOBAL Esoteric Testing MARKET FOR EUROPE BY REGION-2019-2031 (USD MILLION)
Table 21. GLOBAL Esoteric Testing MARKET FOR MIDDLE EAST & AFRICA BY REGION-2019-2031 (USD MILLION)
Table 22. GLOBAL Esoteric Testing MARKET FOR SOUTH AMERICA BY REGION-2019-2031 (USD MILLION)
Table 23. NORTH AMERICA Esoteric Testing Market BY COUNTRY, USD MILLION 2019-2031
Table 24. NORTH AMERICA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 25. NORTH AMERICA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 26. NORTH AMERICA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 27. U.S. Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 28. U.S. Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 29. U.S. Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 30. CANADA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 31. CANADA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 32. CANADA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 33. EUROPE Esoteric Testing Market BY COUNTRY, USD MILLION 2019-2031
Table 34. EUROPE Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 35. EUROPE Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 36. EUROPE Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 37. GERMANY Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 38. GERMANY Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 39. GERMANY Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 40. FRANCE Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 41. FRANCE Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 42. FRANCE Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 43. UK Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 44. UK Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 45. UK Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 46. ITALY Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 47. ITALY Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 48. ITALY Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 49. SPAIN Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 50. SPAIN Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 51. SPAIN Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 52. BENELUX Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 53. BENELUX Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 54. BENELUX Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 55. REST OF EUROPE Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 56. REST OF EUROPE Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 57. REST OF EUROPE Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 58. ASIA PACIFIC Esoteric Testing Market BY COUNTRY, USD MILLION 2019-2031
Table 59. ASIA PACIFIC Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 60. ASIA PACIFIC Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 61. ASIA PACIFIC Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 62. CHINA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 63. CHINA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 64. CHINA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 65. INDIA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 66. INDIA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 67. INDIA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 68. JAPAN Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 69. JAPAN Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 70. JAPAN Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 71. AUSTRALIA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 72. AUSTRALIA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 73. AUSTRALIA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 74. SOUTH KOREA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 75. SOUTH KOREA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 76. SOUTH KOREA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 77. SOUETHEST ASIA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 78. SOUETHEST ASIA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 79. SOUETHEST ASIA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 80. REST OF ASIA PACIFIC Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 81. REST OF ASIA PACIFIC Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 82. REST OF ASIA PACIFIC Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 83. LATIN AMERICA Esoteric Testing Market BY COUNTRY, USD MILLION 2019-2031
Table 84. LATIN AMERICA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 85. LATIN AMERICA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 86. LATIN AMERICA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 87. BRAZIL Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 88. BRAZIL Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 89. BRAZIL Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 90. MEXICO Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 91. MEXICO Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 92. MEXICO Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 93. REST OF LATIN AMERICA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 94. REST OF LATIN AMERICA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 95. REST OF LATIN AMERICA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 96. REST OF LATIN AMERICA Esoteric Testing Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 97. MEA Esoteric Testing Market BY COUNTRY, USD MILLION 2019-2031
Table 98. MEA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 99. MEA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 100. MEA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 101. SOUTH AFRICA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 102. SOUTH AFRICA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 103. SOUTH AFRICA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 104. SAUDI ARABIA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 105. SAUDI ARABIA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 106. SAUDI ARABIA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 107. UAE Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 108. UAE Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 109. UAE Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 110. REST OF MEA Esoteric Testing Market SHARE, by TYPE -2019-2031 (USD MILLION)
Table 111. REST OF MEA Esoteric Testing Market SHARE, by TECHNOLOGY -2019-2031 (USD MILLION)
Table 112. REST OF MEA Esoteric Testing Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 113. KEY EXPANSIONS (2019-2022)
Table 114. KEY MERGERS AND ACQUISITION (2019-2022)
Table 115. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. GLOBAL Esoteric Testing MARKET SHARE, by TYPE -2023 & 2031 (USD MILLION)
Figure 7. GLOBAL Esoteric Testing MARKET , INFECTIOUS DISEASE TESTING -2019-2031 (USD MILLION)
Figure 8. GLOBAL Esoteric Testing MARKET , ONCOLOGY TESTING -2019-2031 (USD MILLION)
Figure 9. GLOBAL Esoteric Testing MARKET , ENDOCRINOLOGY TESTING -2019-2031 (USD MILLION)
Figure 10. GLOBAL Esoteric Testing MARKET , GENETIC TESTING -2019-2031 (USD MILLION)
Figure 11. GLOBAL Esoteric Testing MARKET , TOXICOLOGY TESTING -2019-2031 (USD MILLION)
Figure 12. GLOBAL Esoteric Testing MARKET SHARE, by TECHNOLOGY -2023 & 2031 (USD MILLION)
Figure 13. GLOBAL Esoteric Testing MARKET , ENZYME-LINKED IMMUNOSORBENT ASSAY -2019-2031 (USD MILLION)
Figure 14. GLOBAL Esoteric Testing MARKET , CHEMILUMINESCENCE IMMUNOASSAY -2019-2031 (USD MILLION)
Figure 15. GLOBAL Esoteric Testing MARKET , MASS SPECTROMETRY -2019-2031 (USD MILLION)
Figure 16. GLOBAL Esoteric Testing MARKET , REAL TIME POLYMERASE CHAIN REACTION -2019-2031 (USD MILLION)
Figure 17. GLOBAL Esoteric Testing MARKET , DNA SEQUENCING -2019-2031 (USD MILLION)
Figure 18. GLOBAL Esoteric Testing MARKET SHARE, by END USER -2023 & 2031 (USD MILLION)
Figure 19. GLOBAL Esoteric Testing MARKET , HOSPITAL-BASED LABORATORIES -2019-2031 (USD MILLION)
Figure 20. GLOBAL Esoteric Testing MARKET , INDEPENDENT AND REFERENCE LABORATORIES -2019-2031 (USD MILLION)
Figure 21. MARKET PLAYER POSITIONING, 2022
Figure 22. COMPANY EVALUATION MATRIX
Figure 23. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 24. COMPETITIVE HEATMAP OF KEY PLAYERS

 

Frequently Asked Questions

  • Which is the leading segment in the Global Esoteric Testing Market?

    Based on Type that appears to be dominating in the Esoteric Testing market is Oncology Testing.
  • What are the key factors driving the Global Esoteric Testing Market?

    Increasing incidences of chronic conditions, Innovations in diagnostic technologies, increasing use of companion diagnostic are some of the key factors driving the growth in the market.
  • Which region will contribute notably towards the Global Esoteric Testing Market?

    North America region to contribute the major share towards the market growth.
  • What are the key players in the Global Esoteric Testing Market?

    ARUP Laboratories, Stanford Health Care, Mayo Foundation for Medical Education and Research, Laboratory Corporation of America Holdings, Healius Limited, F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., Athena Esoterix, LLC., Opko Health, Inc., Sonic Healthcare Limited and Others.